Penn Medicine researchers will work with scientists from the Washington University-St Louis, the Universities of Pittsburgh and California-San Francisco and Yale University.
The alliance, Center Without Walls, secured a $20m National Institute of Neurological Disorders and Stroke (NINDS) grant to support the project over five years.
Center Without Walls principal investigator Robert Mach said: “At the end of five years, we hope to have a radioactive tracer that will be able to detect Parkinson’s early on and provide detailed information about the disease’s progression, which is critical for discovering and testing new treatments.”